Agree with you here and I want to see the data ? T
Post# of 157707
These PRs seem too good to be true especially the TNBC PR. Not saying it isn’t but I’d like to see more data also BTD should be a breeze even with the small amount of people injected. A robust phase 3 with a big group of people will tell us how effective Leronlimab really is for TNBC.
Until then we need more information. I’m not sure what to make of these two PRs. December will be nice because I’m interested in all the NASH results.


CytoDyn Inc (CYDY) Stock Research Links
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
— Jeremiah 51:36